ROBAEYS, Geert

Email Alert RSS Feed

Profile

Full Name
ROBAEYS, Geert
Email
geert.robaeys@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  Nevens, F.
Internal UHasselt:  ROBAEYS, Geert
Author:  Janssens, F.

Results 1-8 of 8 (Search time: 0.003 seconds).

Issue DateTitleContributor(s)TypeCat.
12018Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomesVan Hees, S.; Bourgeois, S.; Van Vlierberghe, Hans; Serste, T.; Francque, S.; Michielsen, P.; Sprengers, D.; Reynaert, H.; Henrion, J.; Dastis, S. Negrin; Delwaide, J.; Lasser, L.; Decaestecker, J.; Orlent, H.; Janssens, F.; ROBAEYS, Geert; Colle, I.; Starkel, P.; Moreno, C.; Nevens, F.; Vanwolleghem, T.Journal ContributionA1
22017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience.BIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cool, M.; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertConference MaterialC2
32017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experienceBIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cool, M.; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; D'heygere, F.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertConference MaterialC2
42017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without pegylated interferon: a Belgian experienceBIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Francque, S.; Verlinden, W.; Brixko, C.; Decaestecker, J.; De Galocsy, C.; Janssens, F.; Cool, M.; Van Steenkiste, C.; D'heygere, F.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertJournal ContributionM
52017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experienceBIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Vanwolleghem, T.; Verlinden, W.; Brixco, C.; Decaestecker, J.; de Galocsy, C.; Janssens, F.; Van Overbeke, L.; Van Steenkiste, C.; D'Heygere, F.; Cool, M.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertJournal ContributionA1
62016Belgian Experience with Direct Acting Antivirals in People Who Inject DrugsBIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cools, Mario; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; D'heygere, F.; COOLS, Wilfried; Nevens, F.; ROBAEYS, GeertConference MaterialC2
72016Experience with Direct Acting Agents for the Treatment of Hepatitis C in Flanders.BIELEN, Rob; ROBAEYS, Geert; Cool, M.; Decaestecker, J.; Janssens, F.; George, C.; Laleman, W.; Verslype, C.; CASSIMAN, David; Van der Merwe, S.; Nevens, F.Conference MaterialC2
82016Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugsARAIN, Amber; Bourgeois, S.; de Galocsy, C.; Henrion, J.; Deltenre, P.; d'Heygere, F.; George, C.; Bastens, B.; Van Overbeke, L.; Verrando, R.; BRUCKERS, Liesbeth; Mathei, Catharina; Buntinx, F.; Van Vlierberghe, H.; Francque, S.; Laleman, W.; Moreno, C.; Janssens, F.; Nevens, F.; ROBAEYS, GeertJournal ContributionA1